Thrombectomy

The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel large-bore catheter stroke thrombectomy system.

A system for mechanical thrombectomy treating ischemic stroke demonstrated a high level of sensitivity and specificity compared with human evaluation in a recent clinical trial, according to the manufacturer.

Implementation of an artificial intelligence platform led to improved workflow and significantly improved response time for those with ischemic stroke, according to a poster from the International Stroke Conference.

Pulmonary embolism treatment with a large-bore mechanical thrombectomy system was associated with favorable long-term outcomes, including low mortality and improved hemodynamics, functional capacity and quality of life, a speaker reported.

Large-bore mechanical thrombectomy (FlowTriever, Inari Medical) in patients with high-risk pulmonary embolism.

Among patients with pulmonary embolism who underwent percutaneous thrombectomy, women experienced more procedure complications and mortality than men, according to study results published in CHEST.

NEW ORLEANS — Compared with other treatment options and historical data, large-bore mechanical thrombectomy conferred reduced risk for in-hospital adverse clinical outcomes in high-risk patients with pulmonary embolism, data showed.

Healio and Cardiology Today have compiled a list of the most-read news in CV intervention from TCT 2022.

BOSTON — In patients with intermediate- and high-risk pulmonary embolism, mechanical thrombectomy was safe and linked with good short-term hemodynamic and clinical outcomes, according to data from the FLASH registry.

Although thrombectomy was linked with improved functional recovery in patients with pre-stroke disability, it might also increase the risk for survival with significant disability, according to a study in JAMA Network Open.